UK Markets open in 7 hrs 24 mins
NIKKEI 225
26,739.03 +336.19 (+1.27%) HANG SENG
20,717.24 +596.56 (+2.96%) CRUDE OIL
110.35 +0.46 (+0.42%) GOLD FUTURES
1,845.10 +3.90 (+0.21%) DOW
31,261.90 +8.77 (+0.03%) BTC-GBP
24,267.11 +590.57 (+2.49%)
Kiromic BioPharma, Inc. (KRBP)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | N/A |
| S&P500 52-week change 3 | N/A |
| 52-week high 3 | 11.0000 |
| 52-week low 3 | 0.2910 |
| 50-day moving average 3 | 0.6815 |
| 200-day moving average 3 | 1.7884 |
Share statistics
| Avg vol (3-month) 3 | 360.35k |
| Avg vol (10-day) 3 | 325.72k |
| Shares outstanding 5 | 15.44M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 11.19M |
| % held by insiders 1 | 12.60% |
| % held by institutions 1 | 16.43% |
| Shares short (28 Apr 2022) 4 | 95.35k |
| Short ratio (28 Apr 2022) 4 | 1.33 |
| Short % of float (28 Apr 2022) 4 | 0.63% |
| Short % of shares outstanding (28 Apr 2022) 4 | 0.61% |
| Shares short (prior month 30 Mar 2022) 4 | 198.02k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Dec 2021 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -72.62% |
| Return on equity (ttm) | -132.30% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -24.84M |
| Net income avi to common (ttm) | -25.81M |
| Diluted EPS (ttm) | -2.2410 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 25.35M |
| Total cash per share (mrq) | 1.63 |
| Total debt (mrq) | 454.5k |
| Total debt/equity (mrq) | 1.66 |
| Current ratio (mrq) | 7.94 |
| Book value per share (mrq) | 0.66 |
Cash flow statement
| Operating cash flow (ttm) | -20.32M |
| Levered free cash flow (ttm) | -12.66M |
© 2022 Yahoo. All rights reserved.
